VERU INC. - COMMON STO

Veru Reports Positive Phase 2 Clinical Results of VERU-111 in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

08 2 2021 04:30:00 提供 Nasdaq GlobeNewswire

Veru to Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call on February 10th

27 1 2021 05:30:00 提供 Nasdaq GlobeNewswire

Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become Resistant to Estrogen Receptor Targeted Endocrine and CDK4/6 Inhibitor Therapies

19 1 2021 05:30:01 提供 Nasdaq GlobeNewswire

Veru to Present at the H.C. Wainwright Bioconnect 2021 Conference on January 11th, 2021

04 1 2021 05:30:00 提供 Nasdaq GlobeNewswire